Company Profile
Shandong Anxin Pharmaceutical Co., LtdIt is one of the subsidiaries of Qilu Pharmaceutical Group. It is a modern science and technology enterprise integrating API and preparation production, scientific research, pharmaceutical R & D outsourcing and other businesses. The products cover many fields such as anti-infection, tumor, cardiovascular and cerebrovascular, mental and nervous system, and have formed a complete industrial chain from raw materials to preparation products. The company has advanced anti-tumor chemical synthesis production base, and advanced technology, freeze-drying area of large sterile freeze-drying workshop. It has established a quality control and assurance system in line with international standards. The two series of products of amikacin and tazobactam have passed the drug regulatory agencies of the World Health Organization, the United States, the United Kingdom, Germany, Japan, South Africa and other countries and organizations. Certification. Anxin has a global marketing layout and has established strategic partnerships with many international companies such as Pfizer, Novartis, and Merck. Its products are exported to more than 50 countries and regions around the world; tazobactam and amikacin series API market share The world's first, piperacillin sodium tazobactam sodium sterile preparations for injection are exported to Japan, the United States, Europe, Australia and other countries and regions, with a market share of about 70%. |
An Yexin Xincheng Zhiyuan
Corporate Responsibility: Manufacture of safe, effective and high quality medicines.
The company's products are exported to more than 50 countries and regions, benefiting the 5.6 billion population, accounting for 73.8 per cent of the world's population.